Tramadol, buy tramadol, antibiotics, Weight Loss drugs, weight loss herbs, weight loss herbal formula, weight loss, hair loss, hair growth, baldness, Rx Online, pharmaceuticals, DHEA, Lutein, Prescription, Prescription drug, prescription medications, Propecia.

References: Hair growth and hair loss

Development. 1997 Apr;124(8):1583-91.
The SAR1 gene of Arabidopsis acts downstream of the AXR1 gene in auxin response.

Cernac A, Lincoln C, Lammer D, Estelle M.

Department of Biology, Indiana University, Bloomington 47405, USA.

A screen for suppressors of the auxin resistant mutant axr1 in Arabidopsis thaliana has identified at least three second site suppressor loci called Suppressor of Auxin Resistance (SAR). In this study we focus on the SAR1 gene. Previous studies have documented the effects of the axr1 mutations on auxin-inhibition of root growth, auxin-induced gene expression, seedling morphology and aerial morphology. In this study, we show that the axr1 mutations also affect root hair development and epidermal cell length. The sar1-1 mutation suppresses at least partially, every aspect of the axr1 phenotype. Genetic experiments indicate that this suppression is gene specific. When crossed with the auxin-resistant mutant aux1-7, the suppressor has little affect on auxin response. However, the morphology of sar1-1 aux1-7 inflorescences is different from either of the single mutants indicating that both genes play a role in auxin mediated development of the inflorescence. The sar1-1 mutation also affects morphology in an AXR1 background. sar1-1 plants are shorter than wild-type, have altered leaf morphology, flower earlier than wild-type plants and appear to have reduced cell division in the primary root. In most respects sar1-1 axr1 and sar1 AXR1 plants are indistinguishable, indicating that sar1 both suppresses and is epistatic to axr1. Based on these results, we propose that SAR1 acts after AXR1 and that a major function of AXR1 is to relieve SAR1 mediated repression of auxin response.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9108374&dopt=Abstract

Int J Dermatol. 1997 Feb;36(2):100-3.
Immunohistochemical analysis of procathepsin L and cathepsin B in cutaneous Kaposi's sarcoma.

Thewes M, Engst R, Jurgens M, Borelli S.

Department of Dermatology, Technical University of Munich, Germany.

BACKGROUND: The expression of the proteinases cathepsins L and B are induced in tumors by malignant transformation, growth factors, and tumor promoters suggesting they play an important role in tumor invasion and metastasis. METHODS: By immunohistochemistry, procathepsin L and cathepsin B were studied in patients with Kaposi's sarcoma (KS). Formalin-fixed and paraffin-embedded tissues from 29 cases of KS (AIDS-associated KS, n = 24; non-AIDS-associated KS, n = 5) were immunolabeled with the polyclonal antibody directed against procathepsin L and the antisera directed against cathepsin B. RESULTS: Normal epidermis, eccrine sweat glands, and hair follicle expressed both cathepsins. We also found a positive staining for procathepsin L in normal blood vessels. In both "angiomatous" and "fibroblastic" lesions of KS no expression of these enzymes was observed. CONCLUSIONS: These findings support the hypothesis of a benign autochthonous origin of the lesions, such as a hyperplasia.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9109004&dopt=Abstract

Metabolism. 1997 Apr;46(4):437-40.
Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.

Castelo-Branco C, Martinez de Osaba MJ, Pons F, Fortuny A.

Department of Gynaecology and Obstetrics, Hospital Clinic i Provincial, Barcelona, Spain.

To evaluate the usefulness of D-Trp-6-luteinizing hormone-releasing hormone (LHRH) (triptorelin), a gonadotropin-releasing hormone (GnRH) analog (GnRHa), plus an oral contraceptive (OC) in the treatment of severe hirsutism, a total of 48 women between 19 and 35 years of age suffering from polycystic ovary syndrome (PCOS) with severe hirsutism were studied. Hyperandrogenism of adrenal origin was excluded in all subjects. Twenty-three patients received 3.75 mg D-Trp-6-LHRH intramuscularly monthly for 1 year plus an OC containing 30 micrograms ethinyl-estradiol and 150 micrograms desogestrel. A second group of 25 subjects received an OC containing 35 micrograms ethinyl-estradiol and 2 mg cyproterone acetate (CPA). Immediately before and after months 6 and 12 of therapy, bone mineral density (BMD) and Ferriman-Gallwey scores were evaluated and follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), prolactin (PRL), testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), 17-OH-progesterone (17-OHP), and sex hormone-binding globulin (SHBG) were determined. After 1 year of follow-up study, the combination of a GnRHa plus OC resulted in a decrease of hirsutism similar to that observed in the CPA group (41.9% v 40.5%) and in a suppression of gonadotropins and ovarian steroids in all treated women, without significant changes in bone density. The GnRHa-OC combination can potentially be used in the treatment of hirsutism and hyperandrogenism.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9109850&dopt=Abstract

Buy Lipitor Online

Herbs and Pharmaceuticals Online || Hair Million herbal formula for hair loss and hair growth || Hair growth research references ||